Inmune Bio Inc (INMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 43 | 46 | 38 | 97 | 98 |
| Gross Profit | 43 | 46 | 38 | 97 | 98 |
| Operating Expenses | 8,571 | 6,457 | 6,461 | 5,739 | 7,541 |
| Operating Income | -8,528 | -6,411 | -6,423 | -5,642 | -7,443 |
| Other Income | -35 | -90 | -113 | -191 | -282 |
| Pre-tax Income | -8,563 | -6,501 | -6,536 | -5,833 | -7,725 |
| Net Income Continuous | -8,563 | -6,501 | -6,536 | -5,833 | -7,725 |
| Net Income | $-8,563 | $-6,501 | $-6,536 | $-5,833 | $-7,725 |
| EPS Basic Total Ops | -0.48 | -0.36 | -0.36 | -0.32 | -0.43 |
| EPS Basic Continuous Ops | -0.48 | -0.36 | -0.36 | -0.33 | -0.43 |
| EPS Diluted Total Ops | -0.48 | -0.36 | -0.36 | -0.32 | -0.43 |
| EPS Diluted Continuous Ops | -0.48 | -0.36 | -0.36 | -0.33 | -0.43 |
| EBITDA(a) | $-8,474 | $-6,353 | $-6,356 | $-5,574 | $-7,385 |